A MEDICAL EDUCATION COMMUNITY FOR HEMATOLOGISTS AND ONCOLOGISTS

FEATURED WEBINARS

Breakthrough Therapies for Acute Graft-Versus-Host-Disease

Optimal Use of Autologous Transplantation and Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin’s Lymphoma

The goal of this educational program is to improve the treatment of patients with multiple myeloma (MM) and non-hodgkin lymphoma (NHL) through the dissemination of information about stem cell transplantation and mobilization for autologous hematopoietic cell transplantation. The data for stem cell transplantation in MM is rapidly changing. The techniques of mobilization are still evolving. There is considerable debate regarding the timing and number of transplants for MM and the indications for transplant in NHL. The optimal use of transplant in the disease course and appropriate mobilization could drastically change the treatment of MM and NHL.

ASTCT CAR-T SERIES WEBINARS

CAR-T Basics & Biology

The first in ASTCT’s new CAR-T Webinar Series aired on June 9, 2021 with our speaker, Dr. Marcela Maus, and our moderator, Dr. Armin Ghobadi. This webinar, ‘CAR-T Basics and Biology’ covered an overall review of CAR-T Biology, the general process of generating CAR-T, CAR-T targets, the future directions of CAR-T biology, and more!

The second in ASTCT’s CAR-T Webinar Series aired on June 29, 2021 at 2 PM CT with speaker, Dr. Frederick Locke, and our moderator, Dr. Akshay Sharma. This webinar, ‘Clinical Advances in CAR T-Cell Therapy’ covered a review of approved CAR-T products, practical aspects of referrals, eligibility, leukapheresis, and more!

The third installment of the CAR T Webinar Series from ASTCT. This webinar will feature a presentation by Dr. Scott Goldsmith, highlighting the key areas of CAR T vs. Transplant, including consultation, day-to-day management, sequential therapy, and the pros and cons of each.

The fourth installment of the CAR T Webinar Series from ASTCT. This webinar will feature a presentation by Dr. Martina Pennisi, highlighting the key areas of CAR T toxicity management, including CRS/ICANS grading and management, as well as late post-infusion care.

FEATURED BMT REVIEWS

IMAGE ATLAS

Explore Our Directory of Blood Slides